Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors
Authors
Keywords
-
Journal
Minerva Endocrinologica
Volume 44, Issue 2, Pages -
Publisher
Edizioni Minerva Medica
Online
2019-05-17
DOI
10.23736/s0391-1977.19.02970-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles
- (2019) Maria Caroline Alves Coelho et al. Scientific Reports
- E-cadherin expression is associated with somatostatin analogue response in acromegaly
- (2019) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations
- (2018) Giampaolo Trivellin et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular evidence and clinical importance of β-arrestins expression in patients with acromegaly
- (2018) Maria Caroline Alves Coelho et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals
- (2018) Lara Faggi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas
- (2018) María R. Alhambra-Expósito et al. Scientific Reports
- cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells
- (2018) E. Peverelli et al. CANCER LETTERS
- The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-Human Primates: a Potential Path to Expand and Integrate Its Metabolic Actions
- (2018) Mari C. Vázquez-Borrego et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Type 2 diabetes in neuroendocrine tumors: are biguanides and statins part of the solution?
- (2018) Aura D Herrera-Martínez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis
- (2018) Yi-Bing Hu et al. Gastroenterology Research and Practice
- A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced Growth Hormone Secretion In A First-in-human Clinical Trial
- (2018) Wadim M I de Boon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The future: medical advances in MEN1 therapeutic approaches and management strategies
- (2017) Rachel S van Leeuwaarde et al. ENDOCRINE-RELATED CANCER
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- Genetic Aspects of Pituitary Adenomas
- (2017) Pedro Marques et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
- (2017) Zubing Mei et al. INTERNATIONAL JOURNAL OF CANCER
- A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment
- (2017) E. Peverelli et al. INTERNATIONAL JOURNAL OF CANCER
- Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
- (2017) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
- (2017) Shoeb Ikhlas et al. LIFE SCIENCES
- The genetic background of acromegaly
- (2017) Mônica R. Gadelha et al. Pituitary
- Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes
- (2017) Yuichi Nagata et al. Pituitary
- Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells
- (2017) Jiayin An et al. Oncotarget
- Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas
- (2017) Laura Sanchez-Tejada et al. PLoS One
- BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
- (2017) Alejandro Ibáñez-Costa et al. Scientific Reports
- Novel Genetic Causes of Pituitary Adenomas
- (2016) F. Caimari et al. CLINICAL CANCER RESEARCH
- Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly
- (2016) Federico Gatto et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines
- (2016) Pasi Pennanen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes
- (2016) Sara Pusceddu et al. Future Oncology
- Genetics of gigantism and acromegaly
- (2016) Fady Hannah-Shmouni et al. GROWTH HORMONE & IGF RESEARCH
- Gigantism: X-linked acrogigantism and GPR101 mutations
- (2016) Donato Iacovazzo et al. GROWTH HORMONE & IGF RESEARCH
- Screening for genetic causes of growth hormone hypersecretion
- (2016) Liliya Rostomyan et al. GROWTH HORMONE & IGF RESEARCH
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas
- (2016) N. Chauvet et al. JOURNAL OF NEUROENDOCRINOLOGY
- Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
- (2015) Raúl M. Luque et al. CANCER LETTERS
- X-linked acrogigantism syndrome: clinical profile and therapeutic responses
- (2015) A. Beckers et al. ENDOCRINE-RELATED CANCER
- Mortality in acromegaly: a 20-year follow-up study
- (2015) Elina Ritvonen et al. ENDOCRINE-RELATED CANCER
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache
- (2015) Djordje Marina et al. GROWTH HORMONE & IGF RESEARCH
- Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)
- (2015) Joanne M. de Laat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers
- (2015) Laura C. Hernández-Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer Risk in HBV Patients With Statin and Metformin Use
- (2015) Chang-I. Chen et al. MEDICINE
- Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
- (2015) Katja Kiseljak-Vassiliades et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics
- (2015) Marie Helene Schernthaner-Reiter et al. NEUROENDOCRINOLOGY
- The effect of statins on cancer cells—review
- (2015) Lucyna Matusewicz et al. TUMOR BIOLOGY
- Correlation of ghrelin and growth hormone secretagogue receptor expression with clinical features in human pituitary adenomas
- (2015) JUNWEN WANG et al. Experimental and Therapeutic Medicine
- In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
- (2015) Alejandro Ibáñez-Costa et al. Scientific Reports
- Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185
- (2015) X. Fan et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
- (2015) Judit Dénes et al. PLoS One
- The role of ghrelin in metabolic regulation
- (2014) Jonathan Pinkney CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells
- (2014) E. Peverelli et al. ENDOCRINOLOGY
- Ghrelin Receptor (GHS-R1a) and Its Constitutive Activity in Somatotroph Adenomas: A New Co-targeting Therapy Using GHS-R1a Inverse Agonists and Somatostatin Analogs
- (2014) Yves Mear et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Epidemiology and etiopathogenesis of pituitary adenomas
- (2014) Elena D. Aflorei et al. JOURNAL OF NEURO-ONCOLOGY
- Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
- (2014) M. A. Babcook et al. MOLECULAR CANCER THERAPEUTICS
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
- (2014) Giampaolo Trivellin et al. NEW ENGLAND JOURNAL OF MEDICINE
- AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
- (2014) I Tuominen et al. ONCOGENE
- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
- (2013) Albert Beckers et al. ENDOCRINE REVIEWS
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
- (2013) Laura Chinezu et al. HUMAN PATHOLOGY
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Illuminating somatostatin analog action at neuroendocrine tumor receptors
- (2013) Jean Claude Reubi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
- (2012) Giampaolo Trivellin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Familial pituitary adenomas - who should be tested for AIP mutations?
- (2012) Márta Korbonits et al. CLINICAL ENDOCRINOLOGY
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
- (2012) Tove Lekva et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway
- (2012) T Palumbo et al. ONCOGENE
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
- (2011) Stine Lyngvi Fougner et al. CLINICAL ENDOCRINOLOGY
- Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
- (2011) Masako Kato et al. ENDOCRINE JOURNAL
- Somatostatin-Dopamine Chimeras: A Novel Approach to Treatment of Neuroendocrine Tumors
- (2011) M. Culler HORMONE AND METABOLIC RESEARCH
- Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP
- (2011) J. Córdoba-Chacón et al. JOURNAL OF NEUROENDOCRINOLOGY
- The truncated ghrelin receptor polypeptide (GHS-R1b) is localized in the endoplasmic reticulum where it forms heterodimers with ghrelin receptors (GHS-R1a) to attenuate their cell surface expression
- (2011) Kevin B.S. Chow et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells
- (2011) M Durán-Prado et al. ONCOGENE
- Ghrelin immunoexpression in pituitary adenomas
- (2011) Fabio Rotondo et al. Pituitary
- A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
- (2011) Manuel D. Gahete et al. PLoS One
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families
- (2010) Susana Igreja et al. HUMAN MUTATION
- A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs
- (2010) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
- (2010) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ZAC1 target genes and pituitary tumorigenesis
- (2010) Marily Theodoropoulou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pasireotide and Octreotide Stimulate Distinct Patterns of sst2ASomatostatin Receptor Phosphorylation
- (2010) Florian Pöll et al. MOLECULAR ENDOCRINOLOGY
- Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas
- (2010) Giselle Fernandes Taboada et al. NEUROENDOCRINOLOGY
- Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53
- (2010) Leandro Kasuki Jomori de Pinho et al. NEUROENDOCRINOLOGY
- Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly
- (2009) Marily Theodoropoulou et al. INTERNATIONAL JOURNAL OF CANCER
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas
- (2009) Marianne S. Elston et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment
- (2009) Ana Paula M. Casarini et al. Pituitary
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
- (2008) Chrysanthia A. Leontiou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started